| Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 590 | 2015 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 258 | 2018 |
| Fatty acid-related modulations of membrane fluidity in cells: detection and implications G Maulucci, O Cohen, B Daniel, A Sansone, PI Petropoulou, S Filou, ... Free radical research 50 (sup1), S40-S50, 2016 | 151 | 2016 |
| Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia AG Kotini, CJ Chang, A Chow, H Yuan, TC Ho, T Wang, S Vora, ... Cell stem cell 20 (3), 315-328. e7, 2017 | 142 | 2017 |
| Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute … A Spyridonidis, M Labopin, C Schmid, L Volin, I Yakoub-Agha, M Stadler, ... Leukemia 26 (6), 1211-1217, 2012 | 137 | 2012 |
| A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies MN Gamaletsou, TJ Walsh, T Zaoutis, M Pagoni, M Kotsopoulou, ... Clinical Microbiology and Infection 20 (1), O50-O57, 2014 | 119 | 2014 |
| Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from … A Bazarbachi, G Bug, F Baron, E Brissot, F Ciceri, I Abou Dalle, H Döhner, ... haematologica 105 (6), 1507, 2020 | 115 | 2020 |
| Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients A Spyridonidis, M Labopin, BN Savani, R Niittyvuopio, D Blaise, ... Bone marrow transplantation 55 (6), 1114-1125, 2020 | 107 | 2020 |
| Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies R Marks, K Potthoff, J Hahn, G Ihorst, H Bertz, A Spyridonidis, E Holler, ... Blood, The Journal of the American Society of Hematology 112 (2), 415-425, 2008 | 107 | 2008 |
| High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an … M Liga, E Triantafyllou, M Tiniakou, P Lambropoulou, M Karakantza, ... Biology of Blood and Marrow Transplantation 19 (1), 75-81, 2013 | 86 | 2013 |
| Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic … R Zeiser, A Spyridonidis, R Wäsch, G Ihorst, C Grüllich, H Bertz, J Finke Leukemia 19 (5), 814-821, 2005 | 83 | 2005 |
| Epithelial tissue chimerism after human hematopoietic cell transplantation is a real phenomenon A Spyridonidis, A Schmitt-Gräff, T Tomann, A Dwenger, M Follo, ... The American journal of pathology 164 (4), 1147-1155, 2004 | 81 | 2004 |
| Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients C Heining, A Spyridonidis, E Bernhardt, J Schulte-Mönting, D Behringer, ... Bone marrow transplantation 39 (10), 613-622, 2007 | 71 | 2007 |
| Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives R Zeiser, H Bertz, A Spyridonidis, L Houet, J Finke Bone marrow transplantation 34 (11), 923-928, 2004 | 67 | 2004 |
| Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT B Dholaria, BN Savani, M Labopin, L Luznik, A Ruggeri, S Mielke, ... haematologica 105 (1), 47, 2020 | 60 | 2020 |
| Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell … E Brissot, M Labopin, I Moiseev, JJ Cornelissen, E Meijer, G Van Gorkom, ... Journal of hematology & oncology 13, 1-10, 2020 | 59 | 2020 |
| Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (≥ 60 years) with active myeloid malignancies A Spyridonidis, H Bertz, G Ihorst, C Grüllich, J Finke Blood 105 (10), 4147-4148, 2005 | 59 | 2005 |
| Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow … E Brissot, M Labopin, F Baron, A Bazarbachi, G Bug, F Ciceri, J Esteve, ... Bone marrow transplantation 56 (3), 532-535, 2021 | 54 | 2021 |
| Plasma and serum metabolite association networks: Comparability within and between studies using NMR and MS profiling M Suarez-Diez, J Adam, J Adamski, SA Chasapi, C Luchinat, A Peters, ... Journal of Proteome Research 16 (7), 2547-2559, 2017 | 52 | 2017 |
| Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins A Spyridonidis, M Schmidt, W Bernhardt, A Papadimitriou, M Azemar, ... Blood, The Journal of the American Society of Hematology 91 (5), 1820-1827, 1998 | 48 | 1998 |
